28 results
8-K
EX-99.1
CGTX
Cognition Therapeutics Inc
4 Jan 24
Other Events
4:21pm
that targets Aβ oligomers and α-synuclein oligomers Appx 50% of DLB patients have both Aβ and α-synuclein oligomers present By regulating cellular
8-K
EX-99.1
CGTX
Cognition Therapeutics Inc
12 Sep 23
Other Events
7:00am
identify neurodegeneration targets and treatments. NIH and Advocacy groups help us cost - effectively develop clinical candidates. What we offer … Targets oligomers, a pathogenic form of amyloid plaques produced early in AD Blocks toxic oligomer binding, displaces bound oligomers - protecting
8-K
EX-99.1
ft80j6l4p80v75 ur
24 Aug 23
Regulation FD Disclosure
7:00am
424B4
fxpmbyk1ersg c3
14 Nov 22
Prospectus supplement with pricing info
6:02am
DRS
m212bnbc3ehte4wq
20 Oct 22
Draft registration statement
12:00am
DEF 14A
woawefp
25 Apr 22
Definitive proxy
5:28pm
10-K
i2dweh7bn1 pq
30 Mar 22
Annual report
7:40am
10-Q
r8nra3193c2djousbhc
17 Nov 21
Quarterly report
5:15pm
424B4
fxsw09
12 Oct 21
Prospectus supplement with pricing info
4:11pm